← brief for 2026-08-20 · Slowing decline

Breakthrough - T1DM and Chronic Kidney Disease

Key takeaways

A study using gene-editing to treat kidney disease: a small group of patients with genetic kidney disease will receive an experimental gene therapy. This study is in the preclinical phase using human organoids and mouse models.

Who did this work

Run by University of Chicago.
Sites: Diabetes Research Institute, University of Miami · The University of Chicago

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-20
https://clinicaltrials.gov/study/NCT07592000